Uraki, Ryuta http://orcid.org/0000-0003-0890-1922
Kiso, Maki
Iida, Shun http://orcid.org/0000-0003-2258-9031
Imai, Masaki http://orcid.org/0000-0001-6988-1975
Takashita, Emi http://orcid.org/0000-0002-9064-4699
Kuroda, Makoto
Halfmann, Peter J.
Loeber, Samantha
Maemura, Tadashi
Yamayoshi, Seiya http://orcid.org/0000-0001-7768-5157
Fujisaki, Seiichiro
Wang, Zhongde http://orcid.org/0000-0003-2441-4729
Ito, Mutsumi
Ujie, Michiko
Iwatsuki-Horimoto, Kiyoko http://orcid.org/0000-0002-8266-020X
Furusawa, Yuri
Wright, Ryan
Chong, Zhenlu
Ozono, Seiya http://orcid.org/0000-0002-1764-2937
Yasuhara, Atsuhiro
Ueki, Hiroshi http://orcid.org/0000-0002-6557-0771
Sakai-Tagawa, Yuko
Li, Rong
Liu, Yanan
Larson, Deanna
Koga, Michiko
Tsutsumi, Takeya
Adachi, Eisuke http://orcid.org/0000-0002-1623-873X
Saito, Makoto http://orcid.org/0000-0002-1667-9287
Yamamoto, Shinya
Hagihara, Masao
Mitamura, Keiko
Sato, Tetsuro
Hojo, Masayuki http://orcid.org/0000-0002-9595-9657
Hattori, Shin-ichiro http://orcid.org/0000-0002-5637-3397
Maeda, Kenji http://orcid.org/0000-0002-9424-1491
Valdez, Riccardo
Bennett-Baker, Pamela
Chu, Zijin
Davis, Dawson
Kowalski-Dobson, Theresa
Eckard, Ashley
Gherasim, Carmen
Gremel, Wolf
Lindsey, Kathleen
Manthei, David
Meyers, Alyssa
Moya, Julio Zuniga
Rico, Aaron
Stoneman, Emily
Blanc, Victoria
Sneeringer, Savanna
Warsinske, Lauren
Okuda, Moe
Murakami, Jurika
Duong, Calvin
Godbole, Sucheta
Douek, Daniel C.
Maeda, Ken http://orcid.org/0000-0002-3488-5439
Watanabe, Shinji
Gordon, Aubree http://orcid.org/0000-0002-9352-7877
Ohmagari, Norio
Yotsuyanagi, Hiroshi
Diamond, Michael S. http://orcid.org/0000-0002-8791-3165
Hasegawa, Hideki
Mitsuya, Hiroaki http://orcid.org/0000-0001-9274-3853
Suzuki, Tadaki http://orcid.org/0000-0002-3820-9542
Kawaoka, Yoshihiro http://orcid.org/0000-0001-5061-8296
,
Article History
Received: 19 February 2022
Accepted: 11 May 2022
First Online: 16 May 2022
Competing interests
: Y.K. has received unrelated funding support from Daiichi Sankyo Pharmaceutical, Toyama Chemical, Tauns Laboratories, Shionogi, Otsuka Pharmaceutical, KM Biologics, Kyoritsu Seiyaku, Shinya Corporation and Fuji Rebio. M.S.D. is a consultant for Inbios, Vir Biotechnology, Senda Biosciences and Carnival Corporation, and is on the scientific advisory boards of Moderna and Immunome. The Diamond laboratory has received unrelated funding support in sponsored research agreements from Moderna, Vir Biotechnology, Immunome and Emergent BioSolutions. The other authors declare no competing interests.
Free to read: This content has been made available to all.